Morepen Labs.

31
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
39.53
2.81 (7.65%)
BSENSE

Feb 09

BSE+NSE Vol: 45.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Morepen Labs. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
155.00
135.00
55.00
126.00
98.00
39.00
Adjustment
37.00
34.00
27.00
19.00
31.00
36.00
Changes In working Capital
-123.00
-58.00
-158.00
-181.00
-78.00
-58.00
Cash Flow after changes in Working Capital
69.00
111.00
-74.00
-35.00
52.00
16.00
Cash Flow from Operating Activities
32.00
73.00
-91.00
-60.00
50.00
11.00
Cash Flow from Investing Activities
-321.00
-83.00
-46.00
-31.00
-70.00
-12.00
Cash Flow from Financing Activities
299.00
5.00
143.00
66.00
47.00
5.00
Net Cash Inflow / Outflow
10.00
-4.00
5.00
-25.00
27.00
4.00
Opening Cash & Cash Equivalents
16.00
21.00
15.00
41.00
13.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
27.00
16.00
21.00
15.00
41.00
13.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Morepen Labs.
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
137.59
130.42
7.00
5.50%
Adjustment
31.93
-38.8
69.00
182.29%
Changes In working Capital
-104.37
-0.76
-104.00
-13632.89%
Cash Flow after changes in Working Capital
65.15
90.86
-25.00
-28.30%
Cash Flow from Operating Activities
29.08
74.57
-45.00
-61.00%
Cash Flow from Investing Activities
-280.42
-3.31
-277.00
-8371.90%
Cash Flow from Financing Activities
260.47
-64.15
324.00
506.03%
Net Cash Inflow / Outflow
9.12
7.11
2.00
28.27%
Opening Cash & Cash Equivalents
15.3
44.96
-29.00
-65.97%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
24.43
52.07
-28.00
-53.08%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -56.30% vs 180.48% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
32.06
73.37
-56.30%